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ABSTRACT
Many genetic variations are single nucleotide
polymorphisms (SNPs). Non-synonymous SNPs are
‘neutral’ if the resulting point-mutated protein is not
functionally discernible from the wild type and ‘non-
neutral’ otherwise. The ability to identify non-neutral
substitutions could significantly aid targeting dis-
ease causing detrimental mutations, as well as
SNPs that increase the fitness of particular pheno-
types. Here, we introduced comprehensive data
sets to assess the performance of methods that
predict SNP effects. Along we introduced SNAP
(screening for non-acceptable polymorphisms), a
neural network-based method for the prediction of
the functional effects of non-synonymous SNPs.
SNAP needs only sequence information as input, but
benefits from functional and structural annotations,
if available. In a cross-validation test on over 80000
mutants, SNAP identified 80% of the non-neutral
substitutions at 77% accuracy and 76% of the
neutral substitutions at 80% accuracy. This con-
stituted an important improvement over other
methods; the improvement rose to over ten percen-
tage points for mutants for which existing methods
disagreed. Possibly even more importantly SNAP
introduced a well-calibrated measure for the relia-
bility of each prediction. This measure will allow
users to focus on the most accurate predictions
and/or the most severe effects. Available at http://
www.rostlab.org/services/SNAP
INTRODUCTION
Over 24000 coding SNPs inhuman
Genetic variation drives evolution. Nature shapes life by
selecting genotypes with increased ‘ﬁtness’ for the
encompassing environment. In a rather general sense,
a gain in understanding of the association between genetic
variation and its phenotypic eﬀects is therefore a step
toward grasping how nature acts and how life evolves.
More practically, the study of this association may lead to
understanding what causes various disorders, such as
diabetes or cancer, to appear. A very large portion of
genetic variation is represented by single nucleotide
polymorphisms (SNPs). It has been estimated that as
many as 93% of all human genes contain at least one SNP
and that 98% of all genes are in the vicinity ( 5kb) of
a SNP (4). SNPs occur in both regions that code
for proteins (coding SNPs) and in regions that do not
[non-coding; note that many non-protein-coding
regions are likely to be transcribed as active RNAs
(5,6)]. While non-coding SNPs are trivially more
prevalent, an estimated 24000–60000 coding SNPs
are found in the human genome (4,7). Protein-coding
SNPs can be further divided into synonymous and
non-synonymous (nsSNPs): synonymous SNPs, due to
degeneracy of genetic code, do not change the amino acid
sequence of resulting protein while non-synonymous
SNPs do. Although non-synonymous SNPs generally
have the most obvious functional/biochemical eﬀects,
they do not necessarily associate with functional or
structural consequences.
Non-synonymous coding SNPs(nsSNPs) associated
withdiseases
Non-synonymous SNPs are known to cause numerous
diseases. For example, a point mutation in the hemoglobin
beta gene (substitution of glutamic acid by valine) is one
cause for sickle cell anemia (8). Other diseases, such as
diabetes, have been correlated with a number of SNPs, but
their main genetic factors have yet to be selected from
pools of available candidates. Disease association studies
produce lists of SNPs implicated in a particular disease,
but typically these ‘implications’ span tens of genes and
non-coding regions. Experimentation designed to narrow
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candidates is generally reliable but not guaranteed to
succeed. Additionally, it requires signiﬁcant amounts of
time and may be costly. For instance, one study of nsSNPs
in leukemia-associated Rho guanine nucleotide exchange
factor (LARG) (9), thought to be involved in type
2 diabetes, required the completion of various health
assessments and genotyping of selected SNPs in DNA of
over 1600 individuals. In addition, in vitro functional
assays of the single selected mutant thought to
be functionally non-neutral (Y1306C) merited the trans-
fection of mutants into speciﬁcally maintained cell lines.
Breaking through from a large pool of candidate SNPs
into the light of identifying the mutations causing a
disease is a laborious quest. One challenge on this path is
the prioritization of suspected nsSNPs according to their
likely eﬀects on function. Meeting this challenge requires
the detection of SNPs that may have little eﬀect in
isolation but do damage in concert with others.
In silico methods aid the experimental exploration
of nsSNPs
While experimental methods are more reliable, they are
also more cumbersome than computational studies.
In fact, they are likely to beneﬁt in eﬃciency and speed
from application of some pre-ﬁltering with in silico
predictions of nsSNP eﬀects. Such predictions could be
applied in general to studies of mouse genetics; they would
beneﬁt the elucidation of human mono-SNP and complex
phenotype disorders, as well as evolutionary genetics.
Computational methods may never be accurate enough to
replace wet-lab experiments; however, they may help in
selecting and prioritizing a small number of likely
and tractable candidates from pools of available data.
Recent studies (10–21) have shown that computational
evaluation of certain protein character changes associated
with nsSNPs is capable of giving good estimates of
their functional eﬀects. A range of approaches to
classiﬁcation was considered by these studies including
use of machine-learning [SVM (17,21), decision trees (21),
neural networks (22), random forests (23), Bayesian
models (20), statistical approaches (11,12,16)], and
rule-based systems (15). Similarly diverse were the types
of input information used for the prediction: Some
methods are applicable to all sequences and variations
(e.g. SIFT (14), which uses only mathematical computa-
tions for making inferences from alignments), while others
require speciﬁc types of information, such as the
coordinates of three-dimensional (3D) protein structures
(e.g. SNPs3d (17), which utilizes SVMs to recognize
structural patterns). Some methods combine available
information to improve the classiﬁcation [e.g. PolyPhen
(15), which uses a rule-based cutoﬀ system on available
data including 3D-structures, SWISS-PROT annotations,
and alignments]. All methods perform relatively well when
applied to the data sets on which they were developed.
Despite all of those solutions, the problem of predicting
functional eﬀects of nsSNPs is not solved. Aside from the
desired improvement in accuracy of prediction (which, if
signiﬁcant enough, would make these methods useful
in medical applications such as genetic counseling),
the ﬁeld would beneﬁt from a comparison of performance
across methods. As is, we cannot compare the perfor-
mance of diﬀerent methods from existing publications,
because of the variety of testing sets and evaluation
measures. One of the goals of this work was to compile
a larger and more diverse data set that could fairly be
used for evaluation of methods that require similar types
of inputs.
Despite all limitations of existing methods, quite a
few experimentalists (24–26) describe using them for
facilitating their research practices. For others,
the reluctance to rely on results produced through
computation is likely the relative lack of control
over the ‘black box’ predictions. Making the basis
of predictions clear, as might be possible with decision
tree-based algorithms, would allow the researchers
to select only those cases, which they are willing to
believe. However, the accuracy of classiﬁcation of the
existing tree-utilizing methods [e.g. the Krishnan et al. (21)
implementation] appears to be lower than that of other
available tools. Yet, even these improved methods do not
evaluate all nsSNPs equally well. For experimentalists this
translates into a real possibility of getting the wrong
prediction for the one mutant that they might really
be interested in, without even a hint at a possible
misclassiﬁcation. As an alternative to providing user
control at the cost of accuracy and applicability, we
propose utilizing a reliability scale of predictions. While
this approach may not explain the reasoning behind
assignment of a mutant to either functional class, it will
simplify the choices made on the basis of predictions.
Here we described a novel in silico method, SNAP
(screening for non-acceptable polymorphisms), that could
potentially classify all nsSNPs in all proteins into
non-neutral (eﬀect on function) and neutral (no eﬀect)
using sequence-based computationally acquired informa-
tion alone. For each instance SNAP provides a reliability
index, i.e. a well-calibrated measure reﬂecting the level of
conﬁdence of a particular prediction. SNAP is a neural
network-derived tool that accurately predicted functional
eﬀects of nsSNPs in our newly compiled data set by
incorporating evolutionary information (residue conserva-
tion within sequence families), predicted aspects of protein
structure (secondary structure, solvent accessibility), and
other relevant information. All information needed as
input was obtained from sequence alone. SNAP reﬁned
and extended previous machine-learning tools in
many ways, e.g. by the extensive data set used for
the assessment, by the particular approach to data
handling, and by its ubiquitous applicability (to sequences
from all organisms, proteins with and without known
structures, and entirely novel SNPs in scarcely character-
ized and un-annotated families). Additionally, SNAP
outperformed the competitors throughout the spectrum
of diﬀerent accuracy/coverage thresholds and correctly
estimated its own success through the reliability index.
The importance of the later is that users will be able to
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to be correct; they will also know if one of the
mutants implicated in a malfunction was predicted to be
deleterious with low conﬁdence.
METHODS
Data sets
PMD set. Single amino acid substitutions were extracted
from the Protein Mutant Database (1,2). PMD is
an extensive literature-derived database containing
experimental information about protein mutations and
their eﬀects. Many changes are reported in a qualiﬁed
form (‘signiﬁcant decrease in function’ ‘ ’, ‘no change’
‘¼’, ‘increased aﬃnity’ ‘þ’, etc.). If a particular mutant
appeared more than once with diﬀerent qualiﬁcations,
we assigned this mutant to the non-neutral class.
Otherwise, a single instance of the mutant was added to
the class corresponding to the given qualiﬁcation of the
eﬀect. All mutants associated with a functional change,
independent of direction or strength of signal, were
assigned to the non-neutral class. A total of 4675 protein
sequences containing 54975 single residue mutations were
extracted. Of these 14334 were described as producing no
eﬀect as compared to wild type and 40641 had an eﬀect.
Enzyme set. We extracted many more non-neutral than
neutral SNPs from PMD. Thus, we had to create an
additional large data set of neutral mutations. Others (27)
resolved this issue by considering alignments of closely
related sequences and considering all diﬀerences between
these as neutral. We took a diﬀerent approach by tapping
into SWISS-PROT (28): ﬁrst, we selected all enzymes with
experimentally annotated function. We assumed that all
residues that diﬀered in an alignment of two enzymes,
both of which have been experimentally annotated to have
the same function (same EC number), are neutral. We
excluded all non-experimental annotations (‘by similarity’,
‘by homology’, ‘hypothetical’, ‘putative’ or ‘fragment’
entries). In order to reduce potential errors further,
we restricted the construction of these data to sequence
similar enzymes. Toward this end we aligned all
experimentally annotated enzymes by pairwise BLAST
(29), and selected only pairs that matched two criteria:
(i) pairwise sequence identity 440%, (ii) HSSP-value 40
(30,31). Amino acids that diﬀered between any two
aligned sequences were deemed not likely to aﬀect
function. A total of 2146 sequences, carrying 26840
neutral pseudo-mutants were added to the data set in this
manner (Table SOM_1, Supplementary Data).
Separation bypredicted solventaccessibility
Many studies noted that the location (e.g. buried/exposed)
of a residue within the 3D structure (11,16,17,27) is
relevant for the eﬀect of a particular substitution on
function. We used this observation by dividing the
available mutants into three sets based on predicted
solvent accessibility (buried¼59% exposed surface
area, intermediate¼49 and 536%, exposed¼436%).
Diﬀerent evolutionary pressures exist for residues of dif-
ferent accessibility; this in turn requires the use of slightly
diﬀerent input features for the prediction. Although
the thresholds chosen for this split were relatively
arbitrary, they provided a good estimate of actual classes
of accessibility. The numbers of mutants belonging to
each set were  35000,  25500 and  21000, respectively.
Notably, the fractions of neutral to non-neutral substitu-
tions were markedly diﬀerent by class (0.75, 1.06 and 1.6,
respectively). While our solution suﬀered from mistakes in
predicting accessibility, it had the important advantage of
generating a data set that was many orders of magnitude
larger than any other set that has ever been analyzed with
respect to the accessibility of mutants.
Cross-validation
For all testing purposes we split each of the three
accessibility-grouped data sets, as well as the full data
set, into ten subsets such that no protein in one set had
HSSP-values 40 to any protein in another set (note that
for alignments of4250 residues this implied that no pair
of proteins had over 21% pairwise sequence identity).
No other limitations were imposed on contents of each set.
For each group of ten, we then used eight data sets
for training (optimizing the free parameters), one for
cross-training (determining the point at which training
was stopped), and one for testing. Finally, we rotated
through all sets such that each protein was used for testing
exactly once.
Additional test sets. Although SNAP was extensively
cross-validated, we also evaluated performance on
additional data sets that have previously been used for
benchmarking. These were the mutagenesis data for LacI
repressor from Escherichia coli (32), bacteriophage T4
lysozyme (33), and HIV-1 protease (34). This additional
data set, that has been used previously in evaluation of
other tools (14), and methods (16,27), consisted of 4041
LacI mutants, 2015 Lysozyme mutants, and 336 HIV-1
protease mutants; eﬀects were classiﬁed by: very dam-
aging, damaging, slightly damaging, neutral. In order to
evaluate the performance of SNAP in comparison to
SNPs3D (17), a tool aimed at resolving eﬀects of human
nsSNPs, we utilized a set of 45 non-neutral mutants of the
human melanocortin-4 receptor (C. Vaisse, personal
communication). All SNAP predictions for these sets
(and those currently made by the server) were obtained by
averaging outputs of ten diﬀerent networks trained on
split PMD/EC data as described in the cross-validation
procedure above.
Prediction method
We used standard feed-forward neural networks with
momentum term described elsewhere in detail (35–37).
All free parameters of the networks were chosen without
ever considering the performance of the test sets. Instead,
free parameters were optimized on the training
(optimizing connections) and cross-training (optimizing
architectures/stop training) sets that had no signiﬁcant
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machines [SVMs (38)], however, this worked slightly
worse in our hands. Note that we trained SVMs using
the same features as those selected for the best-performing
neural network and attempted to optimize some of the
free parameters on the cross-training data set. While
the resulting SVM-based method was very accurate
it performed somewhat worse than a comparable neural
network-based method.
Window length. The immediate local sequence environ-
ment of a residue is likely of importance in determining
the eﬀect of a mutation. Our neural networks implicitly
captured this eﬀect by using windows of w consecutive
residues as input; these windows were symmetric
with respect to the central position of the residue
with the SNP. We experimented with window lengths
from 1 (mutant only) to 21 residues.
Selecting protein features for evaluation. Many protein
characteristics may impact the eﬀect of a mutation.
The features that we considered (and described below)
were collected mostly according to what we learned
from previous publications and our experience with
the development of various prediction methods
(Table SOM_2, Supplementary Data).
Bio-chemical properties. Many studies conﬁrmed that
non-neutral substitutions are likely to aﬀect protein
structure (10,11,16,17,27). These include the introduction
of a charged residue into a buried position, or of an
inﬂexible proline into an alpha-helix, the replacement of
hydrophilic by a hydrophobic side-chain or vice versa,
and over-packing or creation of a cavity in the
protein core by changing the size of the residue.
In addition, we considered the change in presence/absence
of Cb-branching and mass of wild-type and mutant
residues.
For each of ﬁrst ﬁve features, one input node was
included into the network architecture indicative of the
change in its value or category due to the mutation. Class
changes (hydrophobicity, charge, size) were represented
by severity of change (e.g. change of residue charge from
positive to negative was assigned an input¼100, positive
to neutral input¼50, positive to positive input¼0). The
presence of buried charge, change in Cb-branching, or an
introduction of proline into an alpha-helix were indicated
by a single binary node (input¼0 or 100). The input
representative of mass change equaled the diﬀerence in
mass between the wild type and mutant. This total of six
nodes made up the minimum set of features to be included
with every network.
Sequence information. Previous studies using sequence
information utilized diﬀerent ways of representing the
amino acid alphabet. We felt that it was best to represent
each residue in the binary 21-node format. This method
allows for maximum resolution in representation and has
proven useful in a number of studies done in our group
(6,36,39,40).
Transition frequencies (likelihood of observing certain
mutations). Using a local (non-redundant at 80%
sequence similarity) database composed of UniProt
(41,42) and PDB (43), we computed the likelihood
of observing each possible combination of three
residues. For each sample, we included six nodes—three
indicating the likelihood of seeing wild-type residue
(in position 1, 2, 3) and three more, similarly structured,
of seeing the mutant residue. (For sequence stretch
LMNLA, where N is mutated to I, consider likelihood
of triplets LMN,M NL, NLA for wild-type and LMI,
MIL, ILA for mutant).
PSI-BLAST profiles. Not surprisingly the degree to
which a residue is conserved in a family of related proteins
is very important for the prediction of any aspects of
protein structure and function. We encoded evolutionary
information in a variety of ways using combinations of
weighted amino acid frequency and PSSM vectors from
PSI-BLAST output. Computation of our numbers began
by running PSI-BLAST(29), in a standard way [54
iterations at h¼0.001, b¼3000 against a database
merging UniProt (44) and PDB (43)]. Calculated
information per position and relative weight of gapless
real matches to pseudo-counts was included for each
representation type (both values were directly taken from
the PSI-BLAST PSSM).
Position-specific independent counts (PSIC). Aside from
the PSI-BLAST PSSM data, we considered the eﬃcacy
of using proﬁles generated by PSIC (position-speciﬁc
independent counts) (3). PSIC is a particular way of
compiling position-speciﬁc weights that considers the
overall level of sequence similarity between the proteins
aligned. In building proﬁles, we adhered to rules similar to
those used in PolyPhen (15). We collected sequences from
a PSI-BLAST run (e¼0.001, b¼500), removed all
those with 494% or 530% sequence identity. If over
ten sequences satisﬁed these criteria, their alignment
[generated by CLUSTAL W (45)] was submitted to
a local version of PSIC. From the resulting PSSM,
we extracted vectors representative of positions of interest
(i.e. mutation position and surrounding residue window).
These were represented in one of three ways: as a full
vector, as a diﬀerence between the score for wild type and
the substitution, or as a three state model of that
diﬀerence (the cutoﬀs set at 0.5 and 1.5).
Predicted 1D structure (PROFsec/PROFacc). The
relative solvent accessibility of each residue was predicted
through the application of PROFacc (35,46,47). This
feature was included by default in all predictions in the
sense that we used these predictions to split our data sets.
However, we additionally evaluated the usefulness of
including the reliability of this prediction and the scaled
accessibility values into the model. Secondary structure
predictions were obtained from PROFsec (35–37) and
included as three state binary- or scale-valued models
(helix/loop/strand). Predictions of 1D structure usually
also come with a prediction for their reliability; we used
these values of prediction reliability as explicit inputs.
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predicting secondary structure and solvent accessibility,
we put pressure on PROFsec and PROFacc to suggest the
1D structure delineated by the entire family of proteins.
This meant that predicted diﬀerences between wild-type
and mutant sequences were not likely to be signiﬁcant.
To stress the changes associated with the mutation, we
additionally ran PROF on the sequences alone. This sort
of prediction is less reliable than its alignment-based
counterpart, so we only considered the absolute diﬀer-
ences between predicted values of accessibility and each of
the secondary structure states for the wild type and the
mutant.
Predicted flexibility (PROFbval). We used predictions
of chain ﬂexibility from PROFbval (48), including a
single scaled node containing the method’s actual output.
Note that the prediction value explicitly conveyed its
reliability.
Family information (Pfam). Information about the
family of the protein is another feature of value in
evaluating importance of particular positions. We
extracted sets of domain/family related information from
Pfam (49), including presence or absence of domain
boundaries in the residue stretch, the model score of this
domain, indication of whether the position is conserved
and whether the mutant is a better match (according to the
BLOSUM62 substitution matrix) to the consensus than
the wild type. Additionally, we noted the presence or
absence of other domains in the surrounding areas of
sequence.
SWISS-PROT annotations. All sequences in the data set
were aligned to the SWISS-PROT database and best hit
for each was selected (e 0.1). Annotations of the position
corresponding to the mutant in the original sequences
were selected. Of interest were ﬁve classes of annotation:
1 (active residues): BINDING, ACT_SITE, SITE, LIPID,
METAL, CARBOHYD, DNA_BIND, NP_BIND,
CA_BIND; 2 (bonding residues): DISULFID, SE_CYS;
3 (posttranslational modiﬁcation residues): MOD_RES,
PROPEP, SIGNAL; 4 (variable residues): MUTAGEN,
CONFLICT, VARIANT; 5 (transmembrane region)
TRANSMEM. A single node (0/100) was indicative of
presence or absence of annotation representative of each
class. An additional sixth node was added to represent the
diﬀerence between scores of wild-type and mutant residues
in the PHAT matrix of transmembrane substitutions (50)
if the residue was annotated to be part of the transmem-
brane region.
SIFT and Polyphen. To determine whether the
correct predictions made by our method overlapped
with those covered by PolyPhen (15) and SIFT (14)
we included the predictions from these two methods as
additional features in the ﬁnalized networks. For SIFT
the input consisted of three nodes—the actual score, the
two class prediction and the number of sequences aligned.
For PolyPhen, we included the two-class prediction
(unknown was grouped with neutral), and a three-node
indication of the source of evidence (structure,
alignment, everything else). However, the inclusion of
PolyPhen predictions did not improve performance of
SNAP
annotated (SNAP using SIFT and SWISS-PROT
annotations).
Feature selection. We trained a number of networks
before the optimal architecture and feature space were
obtained for each data set. The only feature that was
not altered in the network selection process was the
presence of two output nodes, each ranging from 0 to 100.
The diﬀerence between two outputs, sampled at a
particular cutoﬀ, determined the classiﬁcation of the
mutant.
In order to evaluate possible network input
feature combinations, we randomly chose one
cross-training set of ten available for each residue class
and used the rest for training. To avoid hitting local
maxima in training of networks the following procedure
was used:
(1) Train the neural network for 200 repetitions on a
balanced set of all training data points
(2) Determine the accuracy of the network on the
cross-training set after each repetition. Record
the step (max_step) where the overall accuracy
[Equation (2)] is highest.
(3) Train and determine accuracy for cross-training set
at least another max_step/2 times. Change max_step
to reﬂect attempt with highest accuracy and repeat
(3) until no improvement is recorded in additional
steps.
According to the above method, we systematically ran
networks of similar architectures, using an approximation
of the rule of thumb (51) for fully connected networks
[Equation (1)], to attain the best-performing feature at
each run. This feature was added to the input vector
speciﬁc to that accessibility class.
desired number of samples ¼ 10 number of input nodes
 number of hidden nodes:
1
When additional features no longer improved
performance window length, hidden node number, learn-
ing rate and momentum were varied. Further runs were
only attempted if any of the changes stimulated an
increase in overall accuracy. The results of these runs
determined the architecture and input vectors for the ﬁnal
networks.
Measuring performance
Accuracy and coverage. First, we used the overall
two-state accuracy (often referred to as Q2):
Q2 ¼ Overall accuracy
¼
number of correct predictions in both classes
total number of samples:
2
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compiled the measures listed below [Equations (3) and (4)]
and a few others (Table SOM_3, Supplementary Data).
Accuracynon neutral ¼
TP
TP þ FP
Accuracyneutral ¼
TN
TN þ FN
3
Coveragenon neutral ¼
TP
TP þ FN
Coverageneutral ¼
TN
TN þ FP
4
where TP are the true positives (i.e. correctly predicted
non-neutral SNPs) and FP are the false positives
(i.e. neutral SNPs predicted to be non-neutral).
Similarly, TN are the true negatives (i.e. correctly
predicted neutral SNPs) and FN are the false negatives
(i.e. non-neutral SNPs predicted to be neutral;
Table SOM_4, Supplementary Data). We monitored
levels of neutral/non-neutral accuracy and coverage
as a function of the reliability index of prediction
[Equation (6)]. A trade-oﬀ between these two is seen: a
higher RI indicates better accuracy (more predictions
correspond to observations), but lower coverage
(fewer predictions of this type are made). Additionally,
higher non-neutral accuracy corresponds to higher neutral
coverage and vice versa.
Estimates for standard errors. Standard deviation and
error for all measurements were estimated in one of two
ways: over 10 testing sets (PMD/EC set) or over 100 sets
produced by bootstrapping (LacI repressor, lysozyme,
HIV-1 protease, melanocortin-4 receptor). Bootstrapping
(52) was done by randomly selecting (with replacement)
sets of n mutants from the original data set. Thus,
bootstrapped sets may have contained repeats of one
mutant and no instances of another. We then computed
the standard deviation ( ) for each test set (xi) through its
diﬀerence from the overall performance ( x hi ). To compute
standard error for PMD/EC data set,   was divided by the
square root of sample size [n, Equation (5)]:
Standard Deviation ð Þ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
P n
i¼l
xi   x hi ðÞ
2
n
v u u u t
Standard Error ¼
 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n   1
p :
5
Reliability index. The reliability index (RI) for each
prediction was computed by normalizing the diﬀerence
between the two output units (one for neutral, the other
for non-neutral) onto integers between 0 (low reliability)
and 9 (high reliability):
RI ¼ integer
jOutput Unit1   Output Unit2j
10
  
: 6
RESULTS
Feature selection optimized fordifferent classes ofsolvent
accessibility
Which input features predict the functional impact of
SNPs best? Two facts complicated the answer to this
question. First, our data were inconsistent: annotation
varied, e.g. between proteins, between aﬀected tissues, or
between experimental laboratories. Second, the data sets
were also relatively small in the sense that some 80K
mutants are unlikely to cover the entire variety of all
biology (which is essentially what a prediction system
implicitly tries to accomplish). To put this point into
perspective: for the development of secondary structure
prediction methods the 10-fold jump from 100K to 1M
data points increased performance signiﬁcantly (55); for
the prediction of inter-residue contacts 5M data points
still constitute a small data set (56). Our data set was too
small to simply test all possible input features and keep
what works best. In order to prevent overﬁtting, we
therefore had to split the data ﬁrst into subgroups that
were likely to be sensitive to diﬀerent types of changes.
For instance, changes of a hydrophobic into a non-
hydrophobic amino acid may be non-neutral in the
protein core while it may not matter on the surface. We
sought good features in three diﬀerent subsets of buried,
intermediate, and exposed residues (Methods section,
Table SOM_2, Supplementary Data).
The ﬁnal network architectures were: 137 input and
45 hidden nodes for buried residues (window length 5;
the mutant position plus 2 residues on either side of it),
50 input/35 hidden nodes for intermediate residues
(window length 7), and 116 input/20 hidden nodes for
exposed residues (window length 3). Increasing window
length above 7 consecutive residues did not improve
predictions. Shorter windows yielded slightly higher
performance for some settings with the clear tendency of
‘shorter toward the protein surface.’ The input feature
that had the most descriptive value for all three
accessibility classes was the PSIC (3) conservation
weight (Methods section).
Except for PSIC, the input features that were best
diﬀered by class (Figure SOM_1, Supplementary Data).
Best for buried residues were: the simpliﬁed PSI-BLAST
proﬁle, transition frequencies (likelihood of observing the
particular mutation imposed by the SNP), and the
predicted values for residue ﬂexibility (from PROFbval).
Best for intermediate residues were: relative accessibility
scores (PROFacc) and the diﬀerences in predicted
secondary structure and accessibility caused by the SNP
(sequence-only predictions from PROFsec and PROFacc).
Best for exposed residues were: the explicit PSI-BLAST
proﬁle, accessibility scores (PROFacc), raw secondary
structure (PROFsec), and Pfam data.
Best features integrated into SNAP network
Finally, we trained a single network for all classes
of solvent accessibility (buried, intermediate, exposed);
we included all features that helped in any of the
classes. The ﬁnal SNAP network architecture included
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frequency proﬁle, relative solvent accessibility predictions
(PROFacc), secondary structure predictions (PROFsec),
sequence-only predictions of 1D structure (PROFsec/
PROFacc), Pfam information, PSIC scores (Methods
section), predicted residue ﬂexibility (PROFbval),
and transition frequencies (likelihood of observing the
mutation particular mutation imposed by the SNP). With
a window length of ﬁve consecutive residues, this yielded
neural networks with 195 input and 50 hidden units. Note
that none of those parameters were optimized on the test
sets for which we report performance; instead they all were
optimized on the cross-training set (Methods section).
SNAP compared favorably withother toolson the
comprehensive PMD/ECdata
Evaluated on the PMD/EC data (data sets produced by
merging PMD and enzyme data; Methods), SNAP
reached a higher level of overall two-state accuracy
[78%, Equation (2)] than SIFT (74%) and PolyPhen
(75%; Table 1). Given an estimated standard error below
two percentage points, this suggested that SNAP
outperformed SIFT and PolyPhen. The inclusion of
SWISS-PROT annotations and SIFT predictions into
the input vector of SNAP (SNAP
annotated in Table 1)
improved performance even further for both un-annotated
proteins (79%; note: only SIFT predictions) and
annotated ones (81%).
Other methods appeared to reach similar levels of
accuracy suggesting that the majority of mutants in
the data set were classiﬁed similarly by all methods.
This, however, turned out to be a rushed inference,
e.g. SNAP
annotated correctly predicted when the one or
both of the others (SIFT/PolyPhen) were wrong  1.7
times more often than vice versa (SNAP
annotated right
10124 times when SIFT or PolyPhen were wrong;
SNAP
annotated wrong 6117 times when SIFT or
PolyPhen were right.) In other words, for a large
subset of the PMD data set (16241 mutants) for
which at least one method was wrong (i.e. mutants with
hard-to-establish functional eﬀects), SNAP
annotated
achieved an overall accuracy of 62.3%, while
both PolyPhen (7966 right and 8275 wrong) and SIFT
(7566 right and 8675 wrong) attained levels 550%
accuracy.
Performance estimates largely confirmed byindependent
datasets
All our optimizations were performed on PMD/EC data
sets (Methods). We carefully avoided over-optimistic
estimates by a full rotation through three-way 10-fold
cross-validation: training set for optimization of network
connections, cross-training set for optimization of all
other free parameters (hidden units, type of input, etc.),
and the test set for assessing performance. Despite having
applied this time-intensive caution, we wanted to test
yet another independent data set. Overall, the
PMD/EC-based estimates of performance for SNAP
were conﬁrmed by the other data sets (Table 2), namely
for the E. coli LacI repressor, bacteriophage T4 lysozyme,
HIV-1 protease, and human Melanocortin-4 receptor data
(Methods). Although these data sets comprehensively
sampled the space of possible mutations and carefully
evaluated their eﬀects, they covered a minute fraction of
the entire sequence space (four proteins; only one from a
mammal) and may therefore be less representative than
the PMD/EC data. While these additional data were too
limited to suggest ﬁrm conclusions, they helped to conﬁrm
trends. All methods performed slightly less accurately in
terms of the average over all these data than over our
PMD/EC data. The only overlap between these data sets
and the PMD/EC data was in about one quarter of the
LacI mutants (they all were contained in the data used for
the development/assessment of SIFT and PolyPhen).
SNAP still outperformed the competitors on LacI
repressor, Lysozyme, and Melanocortin-4 data. The
performance was radically diﬀerent for the viral sequence:
PolyPhen produced no predictions for any of its mutants
and SNAP performed clearly worse than SIFT. This
disparity might originate from the diﬀerent features used
by each method: SIFT bases its predictions only on
alignments. In contrast, PolyPhen and SNAP also
consider other characteristics (e.g. estimates of secondary
structure, functional regions) that may have been
misleading for this particular case.
High performancethroughout theentire spectrum of
accuracy versus coverage
The SNAP predictions were not binary (neutral or
non-neutral); instead, they were computed as a diﬀerence
between the two output units (one for neutral, the other
Table 1. Performance on PMD/EC set
 
Unk
   Accuracy non-neutral Coverage non-neutral Accuracy neutral Coverage neutral Overall two-state
accuracy
SIFT 2374 79.8 0.6 63.4 1.2 70.1 2.7 84.3 1.2 74.0 1.4
PolyPhen 1647 79.1 0.7 66.9 1.4 71.8 2.7 82.7 1.1 74.9 1.3
SNAP 0 76.7 0.7 80.2 0.9 79.8 2.7 76.2 2.2 78.2 1.3
SNAP
annotated 0 76.3 0.8 83.3 1.0 82.0 2.4 74.7 2.2 78.9 1.3
 Data set: PMD/EC data set (Methods, 39,987 non-neutral and 40,830 neutral mutants). Performance measures: Accuracy is the number correct of
all predicted, coverage is number correct of all observed [Equations (2–4), Methods section]. Both accuracy and coverage are given separately for
neutral and non-neutral mutations. The overall two-state accuracy is the percentage of residues predicted correctly in either of the two classes
(neutral/non-neutral). Standard errors were estimated using the 10-fold split results [Equation (5), Methods section].
  Unk¼Unknown column for PolyPhen and SIFT includes both the predictions that were speciﬁcally classiﬁed by the tool as unknown, as well as
those that could not be computed for whatever reason (e.g. lack of signiﬁcant number of alignments).
Nucleic Acids Research, 2007, Vol. 35, No. 11 3829for non-neutral; diﬀerence ranged from  100 to 100).
‘Dialing’ through diﬀerent decision thresholds (which
diﬀerence yields a prediction of ‘neutral’?) will enable
users to decide which of the two ﬂip sides of the
same accuracy-coverage coin is more important to them.
On the one end of the spectrum, predictions with
very high diﬀerences are very accurate but will cover
very few of the SNPs. On the other end, predictions
with very low diﬀerences will capture all SNPs but this
will be paid for with a signiﬁcantly reduced accuracy.
Thus, dialing through the thresholds generated
ROC-like curves for accuracy versus coverage
(Figure 1). While the predictions of SIFT are also
scaled, the SIFT performance has been optimized for
the default cutoﬀ (arrow in Figure 1). PolyPhen
predictions do not have numerical values; instead they
are sorted into four categories (benign, possibly damaging,
probably damaging and unknown). Thus, given our
assumption of classifying unknowns into the benign
group, only two points exist on PolyPhen’s graph: one
that sorts all damaging values into the non-neutral
class and another that assigns ‘possibly damaging’ SNPs
to the benign category. Since ROC-like curves were only
available for our methods and only partially for SIFT
we didn’t compare methods by their ‘area under the curve’
values. However, SNAP clearly outperformed both
PolyPhen and SIFT throughout the ROC-like curves
(Figure 1). SNAP was only outperformed by
SNAP
annotated, i.e. the version that also considered SIFT
predictions and—when available—SWISS-PROT
annotations.
Reliability indexmeasure provides more confidence in
predictions
The SNAP’s two output units provide for an additional
measure of conﬁdence of prediction. Intuitively, it is clear
that a smaller diﬀerence between the values is indicative of
lower conﬁdence in the prediction. This is also the reason
why accuracy and coverage of predictions are always at a
tradeoﬀ. Higher accuracy predictions are received by
sampling more at more reliable cutoﬀs, thereby reducing
the total number of trusted samples. To deﬁne this
reasoning more precisely we introduced the reliability
index measure [RI; range 0–9, Equation (6)]. Higher
reliability indices correlated strongly with higher accuracy
of prediction. However, the majority of predictions is made
in the middle of the index range (e.g. RI¼5, Figure 2).
Performance better forburied thanfor exposed residues
The SNAP performed better at correctly predicting
non-neutral SNPs in the core of proteins (buried residues)
than those at the surface (exposed residues,
Figure SOM_2, Supplementary Data). This may be due
to better-deﬁned constraints responsible for functional
consequences of altering buried residues (e.g. structural
constraints). Additionally, it may be due to the fact that
there were signiﬁcantly more non-neutral training samples
in the data set localized to the buried regions. Diﬀerent
shape of the accuracy/coverage curves for the neutral and
non-neutral samples is the result of diﬀerent ratios of
neutral to non-neutral samples in various accessibility
classes (Methods section).
DISCUSSION
Featuresimportanttoconservefunctiondifferbetweensurface
and coreSNPs
Although many studies have conﬁrmed the importance
of structure for functional integrity, none have analyzed
mutants in diﬀerent classes of solvent accessibility
(buried, intermediate, exposed). The observation that the
optimal input features diﬀered between these three classes
(Figure SOM_1, Supplementary Data) supported the
intuition of any structural biologist, namely that diﬀerent
biophysical features govern the type of amino acid
substitutions that disrupt function of surface and of core
residues. For instance, the entire proﬁle/PSSM was useful
to determine the eﬀect of substitutions on the surface,
while it suﬃced to consider the frequencies of the original
and the mutant residues at the SNP position to determine
the eﬀects in the core. This diﬀerential behavior could
partially be explained by that internal residues are more
constrained by evolution; therefore, it would suﬃce to
know whether or not the mutated residue ever appears in
an alignment of related proteins. Surfaces, on the other
hand, tend to be less conserved, i.e. many alternatives may
be valid; hence, all of these (full PSSM) must be
considered to determine the eﬀect of a substitution.
Another example of the diﬀerence is the importance of
predicted 1D structure (secondary structure and relative
solvent accessibility) features for the prediction of SNP
eﬀects on the surface (Figure SOM_1, Supplementary
Data). Similar ﬁndings have been reported by other studies
focusing on the prediction of very diﬀerent aspects of
protein function (40,55,56). These 1D features may be
particularly important to determining whether a given
Table 2. Performance on other data sets
 
Method LacI
repressor
Lysozyme HIV-1
protease
Melanocortin-4
receptor
Standard
deviation
3.3 3.7 3.2 3.5
SIFT 69.4 67.6 78.3 57.8
PolyPhen 68.7 57.9
    51.1
SNAP 70.7 70.0 68.5 71.1
SNAP
annotated 72.7 73.2 72.3 75.5
SNPs3D
         62.2
 Data sets: LacI repressor—4041 mutants, Lysozyme—2015 mutants,
HIV-1 protease—336 mutants, Melanocortin-4 receptor—45 mutants.
Methods: as for Table 1, except for: SNPs3D a method predicting
human SNP eﬀects from known 3D structures or proﬁles when
structure modeling is not possible (Melanocortin-4 mutations predicted
from proﬁles). Measure: Percentages are reported for the overall
two-state accuracy [Equation (2), last rightmost column in Table 1].
Highest values in each column is highlighted in bold letters. Note that
the diﬀerences in precision in the reported values reﬂected diﬀerences in
the underlying standard deviation [Equation (5)].
  SNPs3D is optimized for human proteins; predictions for non-human
mutants were therefore not included here.
   PolyPhen made no predictions for HIV-1 protease.
3830 Nucleic Acids Research, 2007, Vol. 35, No. 11position is part of a functional site. Active site involvement
of a buried residue, on the other hand, can hypothetically
be approximated through assessing its ﬂexibility. Indeed,
this would also explain why the predicted ﬂexibility
appeared relatively more relevant for buried residues.
Fewer and less-descriptive features required by the inter-
mediate residue network may indicate the need for struct-
ural or functional characteristics that were not tested and/
or for ﬁner gradation of the data in terms of accessibility.
One crucial aspect of the success of SNAP was the way
in which we generated additional data for presumed
neutral substitutions (anything that is changed between
two non-trivially related enzymes both of which have the
same experimentally characterized EC number).
Interestingly, the performance of SNAP diﬀered
substantially between the set of experimentally neutral
(less accurate) and presumed neutral substitutions
(more accurate). Complete experimental assessments of
all possible substitutions are almost impossible. Studies
generally evaluate mutations suspected in causing some
phenotype. The absence of changes is reported as neutral
although it may in fact be non-neutral by some other
phenotype. Thus, ‘neutrals’ from PMD may be less
reliable than those extracted from enzyme alignments.
Evolutionary information mostimportant, followed by
structural information
The types of predicted features of protein structure and
function that we used as input contributed to the
Figure 1. Performance on PMD/EC data. ROC-like curves giving accuracy versus coverage [Equation (2)] for diﬀerent prediction methods. SIFT
predictions range from 0 to 1; thus the performance of SIFT can be analyzed for the entire accuracy/coverage spectrum, however, SIFT has been
evaluated using a default threshold of 0.05. PolyPhen predictions are not scaled; instead, they are sorted by the gravity of the impact (benign,
possibly damaging, probably damaging and unknown). Therefore, we could not ‘dial’ through the PolyPhen cutoﬀ to generate a ROC-like curve for
PolyPhen. Two points on the graph indicate the diﬀerence in performance due to assignment of ‘possibly damaging’ class to non-neutral or neutral
categories (default ‘possibly damaging’¼damaging). SNAP and SNAP
annotated default thresholds are 0. The defaults for each method are indicated
by arrows corresponding in color to the method. The left panel (A) gives the performance for non-neutral SNP mutants; the right panel (B) gives the
performance for neutral SNP mutants.
Figure 2. Stronger predictions more accurate. Stronger SNAP predic-
tions were more accurate. This allowed the introduction of a reliability
index for SNAP predictions [Equation (6)]. This index eﬀectively
predicted the accuracy of a prediction and thereby enables users to
focus on more reliable predictions. The x-axis gives the percentage of
residues that were predicted above a given reliability index. The actual
values of the reliability index (RI) are shown by numbers in italics above
the curve for neutral mutations (green), and below the curve for non-
neutral mutations (red). The values for 7 and 8 are not explicitly given to
avoid confusion. The y-axis shows the cumulative percentage of residues
correctly predicted of all those predicted with RI n [accuracy, Equation
(2)]. Curves are shown for SNPs with neutral (green diamonds) and non-
neutral (red squares) eﬀects. For instance,  38% of both types of residues
are predicted at indices  5; of all the non-neutral mutations predicted at
this threshold, about 90% are predicted correctly, and of all the neutral
SNPs about  92% are predicted correctly.
Nucleic Acids Research, 2007, Vol. 35, No. 11 3831signiﬁcant improvements of SNAP. However, the most
important single feature, other than the biophysical nature
of the mutant and wild type amino acids, was the
conservation in a family of related proteins (as measured
by the PSIC conservation weight). This ﬁnding conﬁrmed
results from statistical methods applied by Chasman and
Adams (11).
For exposed and buried SNPs another phylogenic
feature, namely the detailed PSSM/proﬁle from the
PSI-BLAST alignment, was the second most relevant
input information. Surprisingly, the information from
SWISS-PROT and Pfam annotations did neither clearly
improve all predictions, nor all accessibility types (more
relevant for surface residues).
If more detailed aspects of structure and function were
available for all proteins, these could be input to networks
to improve performance. For instance, Yue and Moult
(17), have demonstrated that an SVM (Support Vector
Machine, i.e. another machine-learning algorithm) can
distinguish mutants involved in monogenic disease by
considering structural features of the protein aﬀected
by the mutation (e.g. breakage of disulﬁde bond or
over-packing).
PolyPhen also uses available structural features of either
the query protein or its homologue (450% pairwise
sequence identity to experimental structure required);
its structural features include solvent accessibility,
secondary structure, phi-psi dihedral angles, ligand
binding, inter-chain contacts, functional residue contacts
(as annotated in SWISS-PROT), and normalized
B-factors. For proteins for which this data is available,
PolyPhen slightly out-performed both SNAP and
SNAP
annotated (Figure 3B, ‘Structure’). However, these
cases constituted a very small fraction of all the examples
for which we had experimental information about SNP
eﬀects (Figure 3A).
The performance of SNAP improved signiﬁcantly
through using available annotations (Figure 3). SWISS-
PROT indications of active site, mutagen, transmem-
brane, binding, and otherwise important regions
(Methods) allowed for better identiﬁcation of possibly
non-neutral mutations. For instance, using SNAP
annotated
to predict the eﬀects of SNPs in Melanocortin-4 corrected
2 of the 13 incorrect SNAP predictions of non-neutral
eﬀects (data not shown).
In the absence of annotations for structure and
function, the most valuable information is extracted
from alignments and family/domain data (Figure 3).
A similar ﬁnding has been reported previously; namely
in the absence of known 3D structure, evolutionary
information was most relevant to predict SNP eﬀects (16).
SNAP was more sensitive tosevere changes
The distinction of mutants according to the severity of
functional eﬀects illustrated the performance of SNAP
from a diﬀerent angle. The diﬀerence between the two
output nodes of SNAP ranges from  100 to 100;
diﬀerences  1 are considered non-neutral by default.
Higher diﬀerences correspond to more reliable predictions
(Figure 1). SNAP was trained only on experimental data
of binary nature, i.e. the supervised output was either
labeled as non-neutral or as neutral. Did the network learn
implicitly to distinguish between more and less severe
eﬀects? We did not have enough data to analyze this
question rigorously. We did however have limited data
sets (LacI repressor data set containing 4041 mutants)
and a limited grading of severity (neutral/slightly
Figure 3. SNAP versus PolyPhen on subsets of PMD/EC data.
PolyPhen uses diﬀerent types of input information. Here, we separately
analyzed the relevance of each of these sources. Annotation: residues for
which sequence annotations were available (e.g. binding site or
transmembrane region), Structure: residues for which experimental
structural constraints were available, Alignment: residues for which only
alignments (PSIC scores) were available, and Unknown: residues that
were not classiﬁed by PolyPhen. The bars for All give the performance
on the entire data set for orientation. (A) Total number of correct
predictions in each class, (B) Accuracy in each group [Equation (2)].
For the experimental annotations in the PMD/EC data set, only
alignment information was available for most mutants. SNAP performs
slightly better than PolyPhen in the absence of experimental 3D
structure and/or annotation, and slightly worse otherwise. Including
SWISS-PROT annotations and SIFT predictions into SNAP improved
performance for all groups.
3832 Nucleic Acids Research, 2007, Vol. 35, No. 11damaging/damaging/severe) to explore this question.
SNAP clearly performed better on more severe eﬀects
(Figure 4, red bars dominate on the right hand side) and
clearly ‘more neutral’ (Figure 4, green bars dominate left
hand side) changes than those with intermediate eﬀects.
This suggested that the diﬀerence between the output
values did not only reﬂect the reliability of predictions, but
also the severity of the change. Put diﬀerently, more severe
eﬀects corresponded to stronger SNAP predictions.
The reason why SNAP implicitly learned about the
severity of eﬀects was likely of statistical nature: the
most severe and most neutral mutations were most
consistent in the data set.
The levels of accuracy of prediction attained by SNAP
are probably not high enough to make the tool widely
useful in genetic counseling applications. However, this
correlation of severity of change with the reliability
index of prediction makes SNAP highly applicable to
prioritization of suspects from disease-association studies
for follow-up investigations.
SNAP could predict gain of function as well as loss
of function
There is a number of nsSNPs in the PMD data set that are
known to introduce ‘gain of function’ for a particular
protein. Unfortunately, many mutations entail a gain of
one function, but a loss, or retention at same levels,
of another. Additionally, modiﬁcations that lead to loss of
function in one protein may very well correlate with a gain
of function in another (e.g. increased structural ﬂexibility
may suppress or promote function). Given this reality, we
chose not to separate out directions of eﬀects of mutation:
for the purposes of SNAP a gain of function is treated as a
non-neutral sample. However, to illustrate that SNAP can
recognize these mutants consider an example of a few
nsSNPs of the metalloendopeptidase thermolysin
(EC.3.4.24.). A study (57) of this enzyme, described in
PMD, showed that set of 18 nsSNPs of thermolysin
increase its activity (‘gain of function’). SNAP correctly
identiﬁed all of these mutations as non-neutral, with
reliability index range 0–5. Although SNAP is already
capable of recognizing gain of function changes, it would
likely beneﬁt from seeing more of this sort of mutants.
However, extensive data of this type is not currently
available.
SNAP designed to accommodate the needsof large-scale
experimental scans
Two features of SNAP make it particularly useful to
researchers who want to scan large experimental data sets.
The ﬁrst is SNAP’s particular strength is the correct
predictions for the least obvious cases (those for which
existing methods disagree). For such mutants SNAP was
13–17% points more accurate than other methods.
Furthermore, these mutants are generally also the hardest
to pinpoint experimentally since their subtle eﬀects are
more likely to contribute to a phenotype rather than fully
account for it. In a typical experimental scenario in which
experimental observations are likely to have already been
subjected to various analysis tools, this improvement is
likely to be extremely relevant and signiﬁcant. For
example, for the Melanocortin-4 receptor mutants
(Methods and Table 2; C. Vaisse personal communica-
tion), SNAP recognized signiﬁcantly more damaging
mutations than other methods. For instance, the
Arg18Cys mutation, known to decrease protein basal
activity (58), was found to be non-neutral only by SNAP.
Similarly, PolyPhen and SIFT also failed to recognize the
deleterious Asn97Asp mutant, known to strongly aﬀect
ligand binding (59). Overall, SNAP was wrong in only two
of the nineteen instances in which at least one of the four
methods tested was right; in comparison SIFT was wrong
10/19, PolyPhen 13/19, and SNPs3D 8/19. Had SNAP
been available earlier, it would have been a signiﬁcantly
better choice for selecting candidates than any other
method. The analysis of the Melanocortin-4 receptor
appeared representative in light of a similar analysis for
our large data set. The second important novel feature of
SNAP is the introduction of a reliability index that
correlates with prediction accuracy (Figure 2) and allows
ﬁltering out low accuracy predictions. In addition to
providing an estimate about the accuracy, the reliability
index also reﬂects the strength of a functional eﬀect
(Figure 4). This feature is entirely unique for SNAP.
Willmore andbetter experimental data improve SNAP
inthe future?
We established that training separate networks on
separate classes of solvent accessibility was beneﬁcial,
Figure 4. Stronger signals for more severe changes. The reliability index
[Equation (6)] of SNAP reﬂected prediction accuracy (Figure 2).
However, we also observed that more severe changes were predicted
more reliably, i.e. resulted in a higher diﬀerence between the two output
units of SNAP. In order to distinguish mutants according to the
severity of the change they cause, we used the functional eﬀects
observed for the LacI repressor (set from (12), as used in testing SIFT).
Samples in the ‘very slightly damaging’ and ‘slightly damaging’
category were combined into a single ‘intermediate’ category. Given
are normalized percentages of samples in each category (y-axis) for a
given range of diﬀerence values (x-axis). We normalized the predictions
in each ‘severity group’ because the samples for ‘intermediate eﬀects’
were signiﬁcantly under-represented in the experimental data.
Nucleic Acids Research, 2007, Vol. 35, No. 11 3833in principle. Unfortunately, the split yielded too
small data sets. We expect to need 2–5 times more
accurate experimental samples to improve performance.
Furthermore, even the available data were not ideal as
illustrated by the diﬀerences of functional assignments for
the 55 mutants from the LacI repressor between the data
set used for SNAP and those used for SIFT: 51 of these
were considered as non-neutral in training SNAP, while
they were classiﬁed as neutral by the authors of SIFT. We
found that these assignments came from diﬀerent studies
and not from annotation mistakes. Diﬀerent experimental
methods and/or interpretations of results can introduce
noise. Moreover, these data tend to be particularly
inconsistent across species and across protein families,
since a qualitative description of what constitutes an
important change often diﬀers across these experimental
territories.
In order to somehow accommodate these diﬀerences in
our evaluation, we annotated SNPs as non-neutral
whenever there were diﬀerent functional annotations.
This approach somehow helped our method to cope
with alternative annotations, to disregard the direction of
change (gain or loss of function), and the severity of a
change (mild or severe). It is still clear that noise in the
data hampers the development of a better method.
Arguably, mutants at the borderline of neutral/non-
neutral are most important. For instance, a single
mutant associated with a polygenic disorder may
not change function globally; instead it may be the
conjunction of several mutants that makes the diﬀerence.
However, we assume that better predictions for the eﬀect
of single mutants will be the only means of improving the
prediction for complex traits, i.e. polygenic disorders, and
that better experimental data will directly translate to
better prediction methods applying the same framework
that we described.
CONCLUSION
We developed SNAP, a neural-network based tool to be
used for the evaluation of functional eﬀects single amino
acid substitutions in proteins. SNAP utilizes various
biophysical characteristics of the substitution, as well as
evolutionary information, some predicted—or when made
available observed—structural features, and possibly
annotations, to predict whether or not a mutation is
likely to alter protein function (in either direction: gain or
loss). Although such predictions are already available
from other methods, SNAP added important novelty.
Amongst the novel aspects was the improved performance
throughout the entire spectrum of accuracy/coverage
thresholds and the provision of a reliability index that
enables users to either zoom into very few very accurate
predictions, or to knowingly broadcast less reliable ones.
The improved performance translated to many unique and
accurate predictions in our data set. We believe that better
future experimental data will directly translate to better
performance of any prediction method. In the meantime,
experimentalists may already speed up their research by
using our novel method.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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